Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells.
Oncol Rep. 2023 Nov;50(5):201. doi: 10.3892/or.2023.8638. Epub 2023 Sep 29.
Oncol Rep. 2023.
PMID: 37772388
Glioma Cells Acquire Stem-like Characters by Extrinsic Ribosome Stimuli.
Shirakawa Y, Ohta K, Miyake S, Kanemaru A, Kuwano A, Yonemaru K, Uchino S, Yamaoka M, Ito Y, Ito N, Hide T, Shinojima N, Mukasa A, Saito H, Jono H.
Shirakawa Y, et al. Among authors: kanemaru a.
Cells. 2021 Nov 1;10(11):2970. doi: 10.3390/cells10112970.
Cells. 2021.
PMID: 34831193
Free PMC article.
Item in Clipboard
Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.
Miyake S, Miwa T, Yoneda G, Kanemaru A, Saito H, Minoda R, Orita Y, Saito H, Jono H.
Miyake S, et al. Among authors: kanemaru a.
PLoS One. 2020 Oct 8;15(10):e0240216. doi: 10.1371/journal.pone.0240216. eCollection 2020.
PLoS One. 2020.
PMID: 33031450
Free PMC article.
Item in Clipboard
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.
Kanemaru A, Shinriki S, Kai M, Tsurekawa K, Ozeki K, Uchino S, Suenaga N, Yonemaru K, Miyake S, Masuda T, Kariya R, Okada S, Takeshita H, Seki Y, Yano H, Komohara Y, Yoshida R, Nakayama H, Li JD, Saito H, Jono H.
Kanemaru A, et al.
Cancer Cell Int. 2022 Nov 15;22(1):358. doi: 10.1186/s12935-022-02781-x.
Cancer Cell Int. 2022.
PMID: 36376983
Free PMC article.
Item in Clipboard
Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N, Kuramitsu M, Komure K, Kanemaru A, Takano K, Ozeki K, Nishimura Y, Yoshida R, Nakayama H, Shinriki S, Saito H, Jono H.
Suenaga N, et al. Among authors: kanemaru a.
Int J Mol Sci. 2019 Oct 20;20(20):5194. doi: 10.3390/ijms20205194.
Int J Mol Sci. 2019.
PMID: 31635163
Free PMC article.
Item in Clipboard
Construction of a mouse Aos1-Uba2 chimeric SUMO-E1 enzyme, mAU, and its expression in baculovirus-insect cells.
Nakayama T, Yuasa E, Kanemaru A, Saito M, Saitoh H.
Nakayama T, et al. Among authors: kanemaru a.
Bioengineered. 2014 Mar-Apr;5(2):133-7. doi: 10.4161/bioe.27544. Epub 2014 Jan 13.
Bioengineered. 2014.
PMID: 24637489
Free PMC article.
Item in Clipboard
High-yield expression of mouse Aos1-Uba2-fusion SUMO-activating enzyme, mAU, in a baculovirus-insect cell system.
Kanemaru A, Saitoh H.
Kanemaru A, et al.
Biosci Biotechnol Biochem. 2013;77(7):1575-8. doi: 10.1271/bbb.130070. Epub 2013 Jul 7.
Biosci Biotechnol Biochem. 2013.
PMID: 23832333
Free article.
Item in Clipboard
Cite
Cite